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ABSTRACT The action of botulinum neurotoxin on ace-
tylcholine release, and on the structural changes at the pre-
synaptic membrane associated with the transmitter release,
was studied by using a subcellular fraction of cholinergic nerve
terminals (synaptosomes) isolated from the Torpedo electric
organ. Acetylcholine and ATP release were continuously mon-
itored by chemiluminescent methods, To catch the membrane
morphological changes, the quick-freezing method was ap-
plied. Our results show that botulinum neurotoxin inhibits the
release of acetylcholine from these isolated nerve terminals in
a dose-dependent manner, whereas ATP release is not affected.
The maximal inhibition (70%) is achieved at neurotoxin
concentrations as low as 125 pM with an incubation time of 6
min. This effect is not linked to an alteration of the integrity of
the synaptosomes since, after poisoning by botulinum neuro-
toxin type A, they show a nonmodified occluded lactate
dehydrogenase activity. Moreover, membrane potential is not
altered by the toxin with respect to the control, either in resting
condition or after potassium depolarization. In addition to
acetylcholine release inhibition, botulinum neurotoxin blocks
the rearrangement of the presynaptic intramembrane particles
induced by potassium stimulation. The action of botulinum
neurotoxin suggests that the intramembrane particle rearrange-
ment is related to the acetylcholine secretion induced by
potassium stimulation in synaptosomes isolated from the elec-
tric organ of Torpedo marmorata.
Botulinum neurotoxin type A (BoNTx) is a clostridial protein
that acts presynaptically impairing the release of acetylcho-
line (ACh) from cholinergic synapses (see ref. 1 as a review).
The toxin inhibits quantal release (2) at the neuromuscular
junction and at the electric organ of Torpedo marmorata (3),
whereas some authors have reported that nonquantal release
is also affected (4). These functional effects are not followed
by morphological effects shortly after intoxication when
electron microscope thin sections ofpoisoned neuromuscular
junctions (2) or electroplaques (3) have been observed.
However, Hirokawa and Heuser (5) reported that botulinum
toxin prevents the increase of mitochondrial calcium spots in
depolarized frog neuromuscular junctions. In freeze-
fractured neuromuscular preparations, Pumplin and Reese
(6) have studied the effect of BoNTx during electrical or
brown widow spider venom stimulation. They observe that
botulinum toxin decreases the number of vesicle fusion sites
in the active zone induced by spider venom in the presence
of external calcium.
Torpedo electric organ is homologous to the neuromuscu-
lar system, particularly enriched in cholinergic nerve termi-
nals (7). It is a suitable model for correlation of structural and
functional effects of the toxin, since it is a homogeneous and
pure cholinergic innervated tissue. Furthermore, from this
tissue, it is possible to isolate a subcellular fraction of
cholinergic synaptosomes (8). We have previously shown
that the electric organ, as well as the isolated synaptosomes,
is sensitive to botulinum intoxication (3, 9).
On the other hand, several studies have analyzed the
ultrastructural changes occurring at the presynaptic mem-
brane of synaptosomes isolated from the electric organ of
Torpedo during chemical stimulation. The main structural
effect consists ofa rearrangement ofintramembrane particles
(IMPs) on leaflets at either face-the protoplasmic freeze-
fractured membrane face (PF) and the external freeze-
fractured membrane face (EF)-of the synaptosomal plasma
membrane (10-12). BoNTx might be a tool for correlation of
these structural changes observed at the presynaptic mem-
brane to ACh release from cholinergic synaptosomes.
METHODS
T. marmorata specimens were caught from the Catalan coast
and maintained alive in seawater in the Barcelona Marine
Biological Station. Pure cholinergic synaptosomes were pre-
pared from the electric organ of T. marmorata as described
(8). Synaptosomes were recovered in a synaptosomal frac-
tion that contained (in mM) NaCl, 280; KCI, 3; MgCI2, 1.8;
CaC12, 3.4; sucrose, 400; glucose, 5.5; Hepes/NaOH buffer
(pH 6.8), 3.6 and buffered to pH 7 by NaHCO3 (about 5 mM).
All steps of the synaptosomal purification were performed at
4°C. The synaptosomal band represents 0.535 ± 0.018 g of
initial tissue per ml and 0.194 ± 0.02 mg of protein per ml (n
= 17).
Botulinum Neurotoxin Purification. Botulinum complex
was obtained from a culture of Clostridium botulinum type A
(NCTC no. 2916). After acid precipitation of the culture, the
toxin was purified by ion-exchange methods in DEAE-
cellulose chromatography (13). Hemagglutinin was removed
from the toxin complex by affinity chromatography and
DEAE-cellulose chromatography as described (14, 15). In-
traperitoneal mouse LD50 ofthis purified neurotoxin was 0.66
ng/kg. Antiserum against BoNTx was made by injecting
formalin-treated BoNTx emulsified with Freund adjuvant
into a rabbit. The serum obtained from the animal contained
600 international units of type A antitoxin per ml of serum.
Membrane Potential Measurement. The membrane poten-
tial of the cholinergic synaptosomes was monitored by the
fluorescent dye 3,3'-diethylthiadicarbocyanine iodide (4 ,AM)
according to Meunier (16). The fluorescence was measured in
Abbreviations: ACh, acetylcholine; BoNTx, botulinum neurotoxin
type A; EF, external freeze-fractured membrane face; IMP, in-
tramembrane particle; PF, protoplasmic freeze-fractured membrane
face.
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a Kontron fluorimeter (excitation, 610 nm; emission, 668 nm)
and displayed on a pen recorder. When the signal reached a
constant level, valinomycin (Boehringer Mannheim; 0.25
,uM, final concentration) was added to the synaptosomal
membrane to increase the permeability to K+ ions. The
external K+ ion concentration was then step increased and
the changes in the membrane potential were recorded.
Finally, gramicidin D (Boehringer Mannheim; 2.5 AM, final
concentration) was added to obtain the reference value (0
mV). The Nernst equation allows us to calibrate in mV the
fluorescent signals. The response to potassium depolariza-
tion was monitored by adding the dye to the synaptosomal
suspension and increasing KCl concentration to 100 mM. The
resting membrane potential and potassium depolarization
were measured on poisoned (BoNTx, 125 pM, final concen-
tration) and nonpoisoned synaptosomes.
Lactate Dehydrogenase Activity. To assess the synaptoso-
mal membrane integrity after BoNTx poisoning, occluded
lactate dehydrogenase (EC 1.1.1.27) activity was measured
according to described procedures (17, 18).
ACh and ATP Release. ACh and ATP release were con-
tinuously monitored by chemiluminescent methods. ACh
release was detected by a procedure described by Israel and
Lesbats (19). This technique uses the specificity of two
enzymes: acetylcholinesterase (EC 3.1.1.7; Sigma), which
hydrolyzes the ACh liberated from the synaptosomes, and
choline oxidase (EC 1.1.99.1; Sigma), which catalyzes in
presence of 02 the oxidation of previously formed choline
producing betaine and H202. H202 formed is detected with a
photomultiplier tube using luminol and peroxidase (EC
1.11.1.7; Sigma). As the luminol-peroxidase reaction needs
an alkaline pH, synaptosomes were diluted by a factor of 2 in
a modified physiological solution buffered to pH 8.6 with
Tris HCl (50 mM). ACh release was induced by addition of
KCl (100 mM, final concentration). The synaptosomal frac-
tion became intoxicated, during different periods and doses,
in an incubation medium containing BoNTx prior to the
addition of the isoosmotic alkaline luminescent medium.
Controls were incubated under the same conditions, BoNTx
being substituted by an equivalent volume of the physiolog-
ical solution.
ATP was measured (20) by incubating the synaptosomal
fraction in the presence of a luciferin/luciferase (EC
1.13.12.7) mixture (Sigma) in front of a photomultiplier tube.
Samples of the synaptosomal suspension were preincubated
for 10 min with BoNTx (125 pM). Then, luciferin (5 ,ug/ml,
final concentration) and luciferase (40 ,ug/ml, final concen-
tration) were added, and the light emission was monitored in
the same dark chamber as for ACh detection. The ATP
release was recorded as an increase of the light emission on
the background light after addition of KCI (100 mM, final
concentration). Both reactions were calibrated by adding
known amounts of ACh or ATP to the same chemilumines-
cent mixture.
Morphological Procedure. The synaptosomal band became
intoxicated with BoNTx (150 pM, final concentration) during
10 min at room temperature. After centrifugation, the pellet
was resuspended in a small volume of physiological solution.
Chemical stimulation of synaptosomes for freeze-fracture
was performed as follows (10): an aliquot of concentrated
synaptosomal fraction (intoxicated or nonintoxicated) was
placed in a copper plate. Samples were incubated during 30
sec with modified physiological solutions containing high
KCl concentration (100 mM after mixing and substituting
NaCI) and frozen in liquid propane at - 190°C cooled by liquid
nitrogen. Membrane fracture was carried out in a Polaron
E-7900 freeze-etching unit in a vacuum of 10-6 torr (1 torr =
133 Pa) at
-110°C. The cleaved surfaces were shadowed with
platinum and carbon at angles of 450 and 90°, respectively.
The replica thickness was controlled by a quartz thin-film
monitor. After thawing, the replicas were cleaned by sodium
hypochlorite and rinsed in double-distilled water. A Philips
EM 301 electron microscope was used to view the replicas.
All electron micrographs were obtained at original magnifi-
cation of x45,000 with an accelerating voltage of 80 kV.
Freeze-fracture faces from presynaptic membrane were iden-
tified as described (12). Membrane areas were enlarged
photographically to a final magnification of X 150,000 to
facilitate counting of IMPs and measuring of their diameter.
Each experiment was performed in triplicate. Since the
curvature of the fractured presynaptic membranes may
introduce changes in the apparent size and density of IMPs,
only flat regions of the membrane were selected for quanti-
tative analysis.
Statistics. All results are given as means ± SEM and treated
for statistical significance by the Student's unpaired t test.
RESULTS
Membrane Potential and Lactate Dehydrogenase Activity
Measurements. The hypothesis of a good preservation of the
synaptosomal fraction during the poisoning is strengthened
by the finding that BoNTx does not impair the synaptosomal
occluded lactate dehydrogenase activity (76.7% ± 5.1% of
the total activity in nonintoxicated synaptosomes, n = 3;
74.2% ± 5.3% in poisoned synaptosomes, n = 3). On the
other hand, the measurements of synaptosomal membrane
potential by the fluorescent method indicate that the toxin
does not alter the resting potential (-52.0 ± 5.7 mV, control
synaptosomes; -47.9 ± 7.6 mV, poisoned nerve endings).
Moreover, the potassium-induced depolarization is not al-
tered by botulinum intoxication [29.2 ± 5.7 mV (n = 3)
nonintoxicated synaptosomes; 27.4 ± 4.8 mV (n = 3) poi-
soned synaptosomes] (Fig. 1).
Effect of Botulinum Neurotoxin on the ACh and ATP
Release. BoNTx blocks the potassium-induced ACh release
in a dose-dependent manner and saturates at a toxin concen-
tration in the medium of 125 pM, reaching up to 70% of
inhibition (Fig. 2A). The IC50 is calculated at 25 pM. This
effect can be prevented when synaptosomes are preincubated
with the botulinum antiserum. The inhibition of ACh release
from the isolated nerve endings can be detected after 2 min
of BoNTx poisoning, reaching maximal inhibition after 6 min
of incubation with the toxin (Fig. 2B). Since ATP is costored
and coreleased with ACh (21), we have investigated the
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FIG. 1. Membrane potential was monitored by a fluorescent dye.
Changes in the fluorescent signal (AF) in the course of depolarization
were recorded. One milliliter of synaptosomal suspension was
incubated with the dye until the fluorescent intensity reached a base
line. KCI (100 mM, final concentration) was added to the cuvette and
changes of fluorescence from this base line were recorded as a
function of time. Finally, gramicidin D (G) (2.5 jLM, final concen-
tration) was added to completely abolish the membrane potential.
"Intoxicated" synaptosomes (BoNTx) were pretreated with 125 pM
BoNTx during 10 min at room temperature. C, control.
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for ACh detection nor the luciferin-luciferase reaction and,
thus, only ACh and ATP release is detected with these
methods after poisoning.
Action of Botulinum Neurotoxin on the Rearrangement of
IMPs. Analysis of presynaptic membrane of stimulated
synaptosomes shows a decrease in the number of IMPs per
,tm2 at the PF (compare Fig. 4 A-C), whereas at the EF, the
IMP density increases (Fig. 4 B and D). BoNTx treatment of
unstimulated synaptosomes does not affect the density of
IMPs either at the PF or the EF (Table 1). However, K+
stimulation of intoxicated synaptosomes does not result in
any modification in the IMP density at both faces (Fig. 4 E
and F), resembling the particle distribution observed in
resting conditions (Table 1).
Analysis of particle populations, with respect to their sizes,
was performed on both presynaptic membrane faces, by
plotting the number of small (s9.5 nm) and large (>9.5 nm)
IMPs. Table 2 illustrates that the density of small particles
decreases at the PF of stimulated synaptosomes but that of
large particles remains stable. Otherwise, at the EF, the large
particle population increases. BoNTx does not modify the
size of particles in resting conditions but inhibits the size
distribution changes elicited by potassium stimulation. This
inhibition of the rearrangement of IMPs at the presynaptic
membrane produced by BoNTx is similar to that observed
when synaptosomes are stimulated in a Ca2-free medium
(Tables 1 and 2).
DISCUSSION
Isolated nerve terminals of the electric organ of T. marmo-
rata are a pure cholinergic subcellular fraction that can be
very appropriately used to correlate the effect of BoNTx on
the release of ACh (9) and the structural changes elicited at
the presynaptic membrane during synaptosome stimulation
by chemical agents (10-12). We have previously shown (3, 9)
that inhibition of ACh release from the electric organ of T.
marmorata and from pure cholinergic synaptosomes by
BoNTx is highly potent at very low concentrations, as occurs
at the neuromuscular junction (2). Moreover, this inhibition
by BoNTx is dose-dependent (maximal inhibition is achieved
with a concentration of 125 pM), and its effect is prevented
when the synaptosomes are previously incubated with bot-
ulinum antiserum. BoNTx acts very quickly on the synap-
tosomes (6 min), probably because in this preparation the
delay due to the diffusion of the toxin within the extracellular
space of the tissue is avoided, since >10 hr are required to
intoxicate a single prism of Torpedo electric organ (3).
There are some effects of BoNTx on the cholinergic
synaptosomes that are similar to those described in brain
synaptosomal preparations (17). Even with a large dose of
toxin, we only obtain a partial inhibition of ACh release up to
70%, but the toxin concentrations required to inhibit ACh
release in brain synaptosomes are much larger (2.2 mM crude
toxin) than those used in our experiments.
BoNTx blocks the release of ACh but not that of ATP from
pure cholinergic synaptosomes stimulated by high potassium
concentration (9), as occurs in brain synaptosomes (22). By
using our preparation, it has been shown (16) that chemical
stimulation with high external potassium concentration pro-
duces an increase in the synaptosomal membrane potential,
which leads to an influx of Ca2" ions (23). Our results indicate
that BoNTx does not inhibit either the membrane depolar-
ization or the calcium uptake, and they agree with the results
obtained previously at the neuromuscular junction (24),
where the presynaptic ionic currents are not affected by the
toxin. Occluded lactate dehydrogenase activity is not mod-
ified by the toxin. Taken together, these results indicate that
CBoNTx]
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FIG. 2. Dose dependence (A) and time course (B) of botulinum
neurotoxin action. ACh release from isolated nerve terminals was
continuously measured by the chemiluminescent method. ACh
release was triggered by adding KCI up to 100 mM (final concen-
tration). Intoxicated synaptosomes were incubated with BoNTx at
different concentrations during 10 min at room temperature. The
results are expressed as percentage of ACh release inhibition.
Prevention of the effect of the toxin by rabbit antiserum is also shown
(open symbol in A). Results are expressed as means + SEM (n = four
different experiments).
action of BoNTx on ATP release from cholinergic synapto-
somes. Our results show that ATP release is not modified by
the neurotoxin under the same experimental conditions (Fig.
3). BoNTx modifies neither the chemiluminescent reaction
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FIG. 3. Effect of BoNTx on ACh and ATP corelease. ACh and
ATP release was triggered by KCI (100 mM, final concentration) and
measured by either the choline oxidase-peroxidase (ACh release) or
the luciferin-luciferase (ATP release) chemiluminescent method.
Intoxicated synaptosomes were preincubated 10 min in 125 pM
BoNTx prior to depolarization. (A) ACh release. (B) ATP release.
Hatched bars, intoxicated synaptosomes; open bars, nonpoisoned
nerve terminals. Results are presented as means + SEM of released
ACh and ATP per g of initial tissue (git) (n = six different
experiments). Statistical significance is indicated by the asterisk: P
< 0.01.
after poisoning, the nerve terminals are still sealed and
metabolically active.
374 Neurobiology: Marsal et al.
25
Proc. Natl. Acad. Sci. USA 86 (1989)
B
a~~~~~"
~~ ~ ~ ~ ~ ~ i r, D:rs : .,
At
-,4< +
In quick-freezing and freeze-fracture studies, during elec-
tnical stimulation of the frog neuromuscular junction in
presence of 4-aminopyridine, the appearance of large IMPs at
the PF during ACh release has been observed (25, 26). Other
FIG. 4. Electron micrographs of
quick-frozen synaptosomal presynap-
tic membrane in resting condition
(PF, A; EF, B) and after potassium
depolarization (100 mM, final concen-
tration) (PF, C; EF, D). Botulinum
neurotoxin-poisoned synaptosomes
after potassium depolarization (PF,
E; EF, F). (x77,400.)
studies, using glutaraldehyde fixation (27, 28), reported that
electrical stimulation induced IMP rearrangement at the PF
according to their density and size distribution. Similar
results have been described in Torpedo electric organ (29, 30)
Table 1. Density of IMPs before and after BoNTx intoxication
Nonintoxicated synaptosomes Intoxicated synaptosomes
RC K+ 0Ca2+, K+ RC K+
PF 1341 ± 50 (10.8) 818 ± 41* (9.4) 1270 ± 45 (11.2) 13% ± 62 (11.0) 1246 ± 58 (15.3)
EF 398 ± 24 (7.9) 789 ± 40* (8.1) 352 ± 35 (6.9) 388 ± 76 (7.4) 305 ± 38 (13.7)
IMP density (number of particles per Zm2) is expressed as the mean ± SEM. The total area counted (.m2) is indicated
in brackets. RC, resting condition; K+, potassium depolarization (KCl, 100 mM; CaCl2, 3.4 mM); 0 Ca2+, K+, potassium
depolarization in a calcium-free medium (KCI, 100 mM; CaCl2, 0; 2 mM EGTA).
*Statistical significance: P < 0.001.
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Table 2. Changes in the size distribution of IMPs before or after
botulinum intoxication
PF EF
Synaptosomes <9.5 nm >9.5 nm <9.5 nm >9.5 nm
Nonintoxicated
RC 1002 345 185 230
100 mM K+ 509 302 293 442
0 Ca2+ + 100 mM K+ 980 301 156 206
Intoxicated
RC 1176 304 192 247
100 mM K+ 927 390 186 243
The IMP density corresponds to a total area of 1 am2 of
synaptosomal presynaptic membrane. RC, resting condition.
and synaptosomes (10-12). When ACh release is inhibited by
BoNTx, there is a blockade of the rearrangement of IMPs at
the PF and EF, as occurs during chemical stimulation in a
calcium-free medium (12, 30). Since calcium enters into
intoxicated synaptosomes (9), our results show that IMP
rearrangement is related to the ACh release process triggered
by chemical stimulation, and it is not linked to the influx of
calcium into the nerve terminals or to depolarization.
It has been suggested (31) that BoNTx forms channels in
planar lipid bilayers. Then, it might be possible that the
formation ofthese channels could induce an increase ofIMPs
at the presynaptic membrane ofthe stimulated synaptosomes
masking the normal IMP rearrangement. However, we think
that this is not the case in our preparation because we do not
observe an increase of IMP density, or changes in their size
distribution, in poisoned synaptosomes at rest. At the pre-
synaptic plasmalemma of the neuromuscular junction, using
electrical stimulation, botulinum toxin inhibits the appear-
ance of large IMPs at the active zones (6), suggesting that it
blocks synaptic vesicle exocytosis. Even if we cannot detect
synaptic vesicle fusions in our experimental conditions (12),
it would be possible that the increase of large IMPs at the EF
could be a consequence ofthe incorporation of particles from
the synaptic vesicles during the vesicle membrane fusion, and
then BoNTx would inhibit this increase by blocking the
exocytotic process. Alternatively, it has been suggested that
the increase of large particles at the EF during the stimulation
is elicited by the translocation of IMPs from the PF to the EF
at the moment in which ACh is released from the cholinergic
synaptosomes (32). These changes could be related either to
different states of membrane fluidity or to modifications in
the patched-lipidic composition at the presynaptic membrane
during the ACh release (33).
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